These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3275773)

  • 1. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.
    Babany G; Morris RE; Babany I; Kates RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):259-62. PubMed ID: 3275773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cyclosporine in the mouse heterotopic heart transplant model.
    Giardina JJ; Malinowska K; Pifarre R; Hwang MH; Robinson JA; Loeb HS; Lawless CE
    J Heart Transplant; 1990; 9(2):106-13. PubMed ID: 2319367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
    Babany G; Morris RE; Babany I; Shepherd S; Kates RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):893-9. PubMed ID: 2649657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP; Morris RE
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
    Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
    Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
    Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
    Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.